Plain-English translation of NCT05572216 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial compares two approaches to robot-assisted kidney surgery for patients with complex kidney tumors. One group receives surgery with a new 3D imaging system that helps surgeons see the tumor and surrounding kidney tissue more clearly, while the other group receives standard surgery without this advanced imaging. The study will measure whether the 3D imaging helps doctors achieve better results for patients.
Removing kidney tumors while preserving as much healthy kidney tissue as possible is important for long-term health. New 3D imaging technology may help surgeons see the tumor anatomy better and reduce complications, but doctors need to test whether this actually improves patient outcomes.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to receive either standard robot-assisted kidney surgery or the same surgery with the new 3D imaging system. The actual surgery itself will be similar either way — a surgeon will use a robot to remove your tumor while preserving your kidney. After surgery, you will have follow-up visits to check your recovery, kidney function, and long-term health outcomes over time.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
France